Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...

The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

The treatment sees patients given two drugs ... There is currently no cure for Parkinson's disease, a condition which causes a range of difficult physical and psychological symptoms.

The finding emerged during the treatment of two Omani sisters who exhibited rapid disease progression and poor response to ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

According to recent research, astrocyte cell transplantation could revolutionize treatments for neurological disorders such ...